WQ100217 (e) Tabled on 26/08/2026

What representations has the Welsh Government made to the UK Government to ensure that eligible patients in Wales contribute to and benefit from the practical cross-border impacts of the Rare Cancers Act 2026?

To be answered by: Cabinet Minister for Health and Care